MANSFIELD ADVISORS LLP
Company number OC382917 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£500,000
Balance sheet as at 2021-04-05
Overview
- Company type
- Limited Liability Partnership
- Incorporated
- 2013-02-27
- Employees
- 12 (2026 accounts)
- Registered office
- 11 - 13 Cavendish Square, London, W1G 0AN
- Postcode
- W1G 0AN
- Accounts category
- Unaudited Abridged
Accounts
- Last made up to
- 2026-04-05
- Next due by
- 2028-01-05
- Financial year end
- 5 April
Confirmation statement
- Last statement dated
- 2026-02-27
- Next due by
- 2027-03-13
Officers 4 current · 3 resigned
Group structure
Controlled by EPIPHANY CONSULTING LTD — since 2016-06-30
Controlled by ARZHIN LTD — since 2016-06-30
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Contact details
- Website
- mansfieldadvisors.com
We Help Buy, Sell and Create Value in Businesses Award winning strategy consulting firm operating across healthcare, social care and education, life sciences, pharma and veterinary. Find Out More Award Winning Sector Experts London based. European focused. International team. Healthcare Hospitals and clinics, mental health, dental, IVF, clinical labs, diagnostics, primary care, pharmacy, insurance, consumer healthcare and distribution. Read More Social Care and Education Care homes, homecare, complex behavioural care, supported living, housing with care, retirement housing, fostering, SEN schools,…
The class of 2013
23%
of the 530,511 companies incorporated in 2013 are still active today; 75% have since been dissolved.
A fact about the year, not a forecast for this company.